Capra Biosciences develops bioreactor technology that turns byproducts and waste into valuable bio-based materials.
Capra Biosciences's investors include Alumni Ventures, GS Futures, SOSV, E14 Fund, SOSV SF & NY (Fka IndieBio).
Capra Biosciences is headquartered in Alexandria, United States.
Capra Biosciences develops bioreactor technology that turns byproducts and waste into valuable bio-based materials.
Capra Biosciences is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Capra Biosciences — Funding & Investors." VCBacked, November 15, 2024, https://www.vcbacked.co/company/capra-biosciences. Accessed July 20, 2026.
VCBacked. (2024). Capra Biosciences — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/capra-biosciences
{{cite web |title=Capra Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/capra-biosciences |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated